Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bone.
What is Multiple Myeloma?

Multiple myeloma is a form of cancer that affects the bone marrow. The cancer is also called Kahler’s disease, named after an Austrian pathologist called Otto Kahler who first described the condition.

Read More

Overview

Feature Articles

Latest Multiple Myeloma News and Research

Researchers are developing a new class of compounds against various cancers

Researchers are developing a new class of compounds against various cancers

Challenges in High Complexity Flow Cytometry

Challenges in High Complexity Flow Cytometry

Research uncovers potential cause of neurotoxicity due to immunotherapy

Research uncovers potential cause of neurotoxicity due to immunotherapy

New partnership aims to advance predictive tests for multiple myeloma in Ireland

New partnership aims to advance predictive tests for multiple myeloma in Ireland

Neil Bell appointed as Chief Development Officer of Avacta Life Sciences

Neil Bell appointed as Chief Development Officer of Avacta Life Sciences

New alpha-radioimmunotherapy for multiple myeloma shows promise in preclinical study

New alpha-radioimmunotherapy for multiple myeloma shows promise in preclinical study

Chemists discover a way to create synthetic version of natural anti-cancer compound

Chemists discover a way to create synthetic version of natural anti-cancer compound

Waterloo tech profiles antibodies in blood of COVID-19 patients

Waterloo tech profiles antibodies in blood of COVID-19 patients

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

Fox Chase and BGU receive grant for cancer treatment study

Fox Chase and BGU receive grant for cancer treatment study

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

New cancer vaccine shows promising signs in preclinical studies

New cancer vaccine shows promising signs in preclinical studies

Mapping immune landscape of hematological malignancies may help improve cancer therapies

Mapping immune landscape of hematological malignancies may help improve cancer therapies

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

New review analyzes appropriateness of off-pathway cancer care

New review analyzes appropriateness of off-pathway cancer care

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

New tool may predict best treatment for multiple myeloma

New tool may predict best treatment for multiple myeloma

Combination therapy does not show superior efficacy in newly diagnosed myeloma

Combination therapy does not show superior efficacy in newly diagnosed myeloma

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program